Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such ...

Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology ...

Scientists have developed a hydrogel “rest stop” that shields cancer-fighting T cells, delaying their exhaustion and boosting ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

While cancer-associated fibroblasts (CAFs) significantly influence tumor progression, their temporal dynamics remain poorly understood. We investigated time-dependent interactions between non-small ...

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

A novel microfluidic chip device for the isolation and analysis of circulating tumour cells (CTCs) in breast cancer has been ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...